Ensysce Biosciences (ENSC) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ENSC Ensysce Biosciences

Watchlist

0.4788
+0.0488+11.35%

Close Nov 25 16:00 ET

0.4770
-0.0018-0.38%

Post 17:11 ET

9.37MMarket Cap-246P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Shareholders Will Likely Find Ensysce Biosciences, Inc.'s (NASDAQ:ENSC) CEO Compensation Acceptable
Simply Wall StNov 14 06:48 ET
Express News | Ensysce Biosciences Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results
BenzingaNov 13 08:17 ET
Ensysce Biosciences GAAP EPS of $0.07 Beats by $0.24
Seeking AlphaNov 12 17:51 ET
10-Q: Q3 2024 Earnings Report
SECNov 12 16:31 ET · Announcements
8-K: Ensysce Biosciences Reports Third Quarter 2024 Financial Results
SECNov 12 16:21 ET
Express News | Ensysce Biosciences Q3 Net Income USD 700 Thousand
ReutersNov 12 16:17 ET

Comments

$Ensysce Biosciences (ENSC.US)$ if no dilution post split price target is 60-300$ if ph3 is successful and FDA approves

$Ensysce Biosciences (ENSC.US)$ the floor is soon

1

1

$Ensysce Biosciences (ENSC.US)$ I will never be well for those shorties

$Ensysce Biosciences (ENSC.US)$ shorties have eventually got hold of this so sad

3

$Ensysce Biosciences (ENSC.US)$ this currently has 8,770,000 Free float and even if they do RS of 1:10 we would have 870k post RS then with FDA approvals and PH3 positive results, am holding for gold 150$

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data